<DOC>
	<DOCNO>NCT02227342</DOCNO>
	<brief_summary>Manipulation intestinal microbiota FMT potential therapeutic target IBD patient . Studies require determine repeat FMT overcome apparent immune response FMT thereby maintain sustain clinical improvement remission . Prior large randomize controlled trial FMT UC carry feasibility study determine serial FMTs sustain clinical response maintain stability transplant microbiota .</brief_summary>
	<brief_title>Fecal Microbiota Transplantation ( FMT ) Management Active Ulcerative Colitis</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<criteria>1 . Age &gt; 18 &lt; 65 year 2 . Diagnosis UC &gt; 3 month &lt; 5 year prior screen determine investigator 3 . Those mild moderate UC 4 . Those failed maintenance therapy stable dos 5ASA , azathioprine 6 mercaptopurine ( 6MP ) &gt; 3 month 5 . Where applicable , take following medication must stable dose define : ) 5ASA must stable dose 2 week ii ) Prednisone 20 mg/d must stable dose 2 week iii ) Budesonide 6 mg/d must stable dose 2 week iv ) Azathioprine 6MP must stable dose &gt; 8 week 6. ability provide inform consent 7. evidence active inflammation 1 . Those whose disease limit rectum ( ie . proctitis ) 2 . Those colectomy divert ileostomy 3 . Those pregnancy plan pregnant trial 4 . Those breastfeed plan breast feed trial 5 . Those previously fail biological agent 6 . Those active infection require antibiotic therapy 7 . Those positive stool culture know pathogen E coli , Salmonella , Shigella , Yersinia , Campylobacter , Clostridium difficile toxin within 2 week enrollment 8 . Those positive CMV colonic tissue biopsy within 2 week screen 9 . Those allergy ciprofloxacin metronidazole 10 . Those colonic mucosal dysplasia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>